Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??

16,000 shareholders,none of whom holds more than about 8% of the company...That is still 32 mil shares

posted on Sep 13, 2007 04:20AM
S&L I can only assume.
Share
New Message
Please login to post a reply